Last updated: N/A
Sponsor: N/A
Overall Status: Active - Recruiting
Phase
2
Condition
Alpha 1 Antitrypsin Deficiency
Treatment
N/AClinical Study ID
TX232161
Ages 18-78 All Genders
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
- Male or female between the ages of 18 and 78 (inclusive)
- Female participants must be of non-childbearing potential (i.e., postmenopausal or have a history of hysterectomy or bilateral removal of the ovaries)
- Diagnosed with Alpha-1 Antitrypsin Deficiency
- Have the genetic pattern most commonly associated with Alpha-1 (the PiZZ genotype)
- A genetic blood test will be used to confirm genotype
- Have never been treated with gene therapy
- Do not smoke cigarettes and/or use electronic nicotine delivery systems (i.e., electronic cigarettes, vape pens) or chewing tobacco products
- Willing and able to comply with the study instructions
- There are additional eligibility requirements, which the study doctor can explain to you
Study Design
Study Start date:
Estimated Completion Date:
Study Description
Connect with a study center
Alpha 1 Study Center
Gainesville, Florida 32610
United StatesActive - Recruiting
Alpha 1 Study Center
Orlando, Florida 32803
United StatesActive - Recruiting
Alpha 1 Study Center
Kansas City, Kansas 66160
United StatesActive - Recruiting
Alpha 1 Study Center
Hannibal, Missouri 63401
United StatesActive - Recruiting
Alpha 1 Study Center
Buffalo, New York 14202
United StatesActive - Recruiting
Alpha 1 Study Center
Chapel Hill, North Carolina 27517
United StatesActive - Recruiting
Alpha 1 Study Center
Houston, Texas 77380
United StatesActive - Recruiting
Alpha 1 Study Center
Salt Lake City, Utah 84108
United StatesActive - Recruiting
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.